Myriad Genetics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Myriad Genetics generated cash of -$110,900,000, which is less than the previous year. Cash used in financing activities reached the amount of $152,900,000 last year. Net change in cash is therefore $74,500,000.
Cash Flow
| 2010 | 155.08M | -76.66M | -49.08M |
|---|---|---|---|
| 2011 | 130.75M | -54.39M | -116.59M |
| 2012 | 141.84M | -38.88M | -69.24M |
| 2016 | 166.3M | -91.4M | -68.3M |
| 2018 | 115.9M | -11.6M | -95M |
| 2020 | 83.7M | -286.4M | 182.3M |
| 2020 | -26.9M | 61.6M | -1M |
| 2021 | 18.2M | 274.4M | -150.6M |
| 2023 | -110.9M | 31.9M | 152.9M |
MYGN Cash Flow Statement (2010 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 66.4M | 117M | 93.2M | 110.9M | 102.4M | 64.1M | 52.68M | 92.84M | 63.51M |
Operating activities | |||||||||
Net income | -263.3M | -27.2M | -223.7M | 4.6M | 131M | 125.3M | 112.15M | 100.71M | 152.30M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 61.9M | 62.8M | 71.4M | 73M | 54.4M | 26.7M | 9.06M | 7.21M | 7.08M |
Stock-based compensation expense | 40.7M | 36.3M | 24.3M | 33.5M | 27.1M | 31.6M | 26.27M | 25.08M | 22.77M |
| Deferred income tax benefit | 40.7M | 36.3M | 24.3M | 33.5M | 27.1M | 31.6M | 26.27M | 25.08M | 22.77M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 3.8M | -8.8M | 28.9M | -18.2M | -39.2M | -39.2M | -34.94M | -14.98M | -21.66M |
Inventories | -1.8M | 1.6M | 1.3M | 8M | 7.9M | -14.6M | -3.42M | 203K | 0 |
Accounts payable | -3.7M | 9.2M | 0 | 1.1M | 4M | -11.4M | -1.24M | 287K | -5.30M |
Cash generated by operating activities | -110.9M | 18.2M | -26.9M | 83.7M | 115.9M | 166.3M | 141.84M | 130.75M | 155.08M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -147.8M | 0 | -78.5M | -80.9M | -164.5M | -396.06M | -425.15M | -477.55M |
Investments In Property Plant And Equipment | -73.3M | -18M | -13.2M | -8.6M | -8.4M | -5M | 0 | -3.79M | 0 |
Acquisitions Net | 0 | 379.1M | 0 | -278.5M | 8.4M | -37M | -9M | -79M | 0 |
Cash generated by investing activities | 31.9M | 274.4M | 61.6M | -286.4M | -11.6M | -91.4M | -38.88M | -54.39M | -76.66M |
Financing activities | |||||||||
Common Stock Issued | 117.6M | 91.8M | 0 | 8.7M | 36.9M | 0 | 0 | 25.06M | 22.30M |
Payments for dividends | 0 | 0 | 0 | -340M | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -3.9M | -50M | 0 | -162.6M | -128.46M | -200.49M | -71.39M |
Repayments of term debt | 39.8M | -226.4M | -8.6M | -115M | -143M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 152.9M | -150.6M | -1M | 182.3M | -95M | -68.3M | -69.24M | -116.59M | -49.08M |
Net Change In Cash | 74.5M | 141.4M | 70.5M | -17.7M | 8.5M | 4.4M | 33.67M | -40.15M | 29.33M |
Cash at end of period | 140.9M | 258.4M | 163.7M | 93.2M | 110.9M | 68.5M | 86.35M | 52.68M | 92.84M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |